These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37861456)

  • 1. Breaking bad buttons: mescaline biosynthesis in peyote.
    Kirschner GK
    Plant J; 2023 Nov; 116(3):633-634. PubMed ID: 37861456
    [No Abstract]   [Full Text] [Related]  

  • 2. Elucidation of the mescaline biosynthetic pathway in peyote (Lophophora williamsii).
    Watkins JL; Li Q; Yeaman S; Facchini PJ
    Plant J; 2023 Nov; 116(3):635-649. PubMed ID: 37675639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dark Classics in Chemical Neuroscience: Mescaline.
    Cassels BK; Sáez-Briones P
    ACS Chem Neurosci; 2018 Oct; 9(10):2448-2458. PubMed ID: 29847089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peyote and mescaline exposures: a 12-year review of a statewide poison center database.
    Carstairs SD; Cantrell FL
    Clin Toxicol (Phila); 2010 May; 48(4):350-3. PubMed ID: 20170392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas.
    El-Seedi HR; De Smet PA; Beck O; Possnert G; Bruhn JG
    J Ethnopharmacol; 2005 Oct; 101(1-3):238-42. PubMed ID: 15990261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis.
    Ibarra-Laclette E; Zamudio-Hernández F; Pérez-Torres CA; Albert VA; Ramírez-Chávez E; Molina-Torres J; Fernández-Cortes A; Calderón-Vázquez C; Olivares-Romero JL; Herrera-Estrella A; Herrera-Estrella L
    BMC Genomics; 2015 Sep; 16(1):657. PubMed ID: 26330142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.
    Dinis-Oliveira RJ; Pereira CL; da Silva DD
    Curr Mol Pharmacol; 2019; 12(3):184-194. PubMed ID: 30318013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of mescaline in peyote.
    Agurell S; Lundström J; Sandberg F
    Tetrahedron Lett; 1967 Jun; 26():2433-5. PubMed ID: 6044217
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosynthesis of the peyote alkaloids. The incorporation of tyrosine-2-C14 into mescaline and anhalonidine.
    Leete E
    J Am Chem Soc; 1966 Sep; 88(18):4218-21. PubMed ID: 5914392
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosynthesis of mescaline and anhalamine in peyote. IIa.
    Lundström J; Agurell S
    Tetrahedron Lett; 1968 Aug; (42):4437-40. PubMed ID: 5672059
    [No Abstract]   [Full Text] [Related]  

  • 11. GC-MS and GC-MS/MS in PCI mode determination of mescaline in peyote tea and in biological matrices.
    Gambelunghe C; Marsili R; Aroni K; Bacci M; Rossi R
    J Forensic Sci; 2013 Jan; 58(1):270-8. PubMed ID: 22900815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isolation of an O-methyltransferase from peyote and its role in the biosynthesis of mescaline.
    Basmadjian GP; Paul AG
    Lloydia; 1971 Mar; 34(1):91-3. PubMed ID: 5140268
    [No Abstract]   [Full Text] [Related]  

  • 13. Marching to a different cactus: peyote (mescaline) intoxication.
    Mack RB
    N C Med J; 1986 Mar; 47(3):137-8. PubMed ID: 3457285
    [No Abstract]   [Full Text] [Related]  

  • 14. Mescaline: a survey.
    Schwartz RH
    Am Fam Physician; 1988 Apr; 37(4):122-4. PubMed ID: 3358338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peyote identification on the basis of differences in morphology, mescaline content, and trnL/trnF sequence between Lophophora williamsii and L. diffusa.
    Aragane M; Sasaki Y; Nakajima J; Fukumori N; Yoshizawa M; Suzuki Y; Kitagawa S; Mori K; Ogino S; Yasuda I; Nagumo S
    J Nat Med; 2011 Jan; 65(1):103-10. PubMed ID: 20890669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro immunopotentiating properties and tumour cell toxicity induced by Lophophora williamsii (peyote) cactus methanolic extract.
    Franco-Molina M; Gomez-Flores R; Tamez-Guerra P; Tamez-Guerra R; Castillo-Leon L; Rodríguez-Padilla C
    Phytother Res; 2003 Nov; 17(9):1076-81. PubMed ID: 14595591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peyote and related alkaloids. XVI. Synthesis of 3,4,5-trimethoxyphenylalanine, an amino acid analog of mescaline.
    Sethi ML; Rao GS; Kapadia GJ
    J Pharm Sci; 1973 Nov; 62(11):1802-6. PubMed ID: 4758076
    [No Abstract]   [Full Text] [Related]  

  • 18. The association between naturalistic use of psychedelics and co-occurring substance use disorders.
    Rabinowitz J; Lev-Ran S; Gross R
    Front Psychiatry; 2022; 13():1066369. PubMed ID: 36704738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of the peyote alkaloids.
    Paul AG
    Lloydia; 1973 Mar; 36(1):36-45. PubMed ID: 4576312
    [No Abstract]   [Full Text] [Related]  

  • 20. Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation.
    Fickenscher A; Novins DK; Manson SM
    Subst Use Misuse; 2006; 41(8):1139-54. PubMed ID: 16798681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.